Literature DB >> 20054722

Candida albicans biofilm formation on peptide functionalized polydimethylsiloxane.

Kristof De Prijck1, Nele De Smet, Monika Rymarczyk-Machal, Gonzalez Van Driessche, Bart Devreese, Tom Coenye, Etienne Schacht, Hans J Nelis.   

Abstract

In order to prevent biofilm formation by Candida albicans, several cationic peptides were covalently bound to polydimethylsiloxane (PDMS). The salivary peptide histatin 5 and two synthetic variants (Dhvar 4 and Dhvar 5) were used to prepare peptide functionalized PDMS using 4-azido-2,3,5,6-tetrafluoro-benzoic acid (AFB) as an interlinkage molecule. In addition, polylysine-, polyarginine-, and polyhistidine-PDMS surfaces were prepared. Dhvar 4 functionalized PDMS yielded the highest reduction of the number of C. albicans biofilm cells in the Modified Robbins Device. Amino acid analysis demonstrated that the amount of peptide immobilized on the modified disks was in the nanomole range. Poly-d-lysine PDMS, in particular the homopeptides with low molecular weight (2500 and 9600) showed the highest activity against C. albicans biofilms, with reductions of 93% and 91%, respectively. The results indicate that the reductions are peptide dependent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054722     DOI: 10.1080/08927010903501908

Source DB:  PubMed          Journal:  Biofouling        ISSN: 0892-7014            Impact factor:   3.209


  10 in total

1.  Prevention of Candida albicans biofilm formation by covalently bound dimethylaminoethylmethacrylate and polyethylenimine.

Authors:  Kristof De Prijck; Nele De Smet; Tom Coenye; Etienne Schacht; Hans J Nelis
Journal:  Mycopathologia       Date:  2010-05-11       Impact factor: 2.574

2.  Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans.

Authors:  Tristan Rossignol; Bridie Kelly; Curtis Dobson; Christophe d'Enfert
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

3.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

4.  Candida biofilms and the host: models and new concepts for eradication.

Authors:  Hélène Tournu; Patrick Van Dijck
Journal:  Int J Microbiol       Date:  2011-11-14

Review 5.  In vitro and ex vivo systems at the forefront of infection modeling and drug discovery.

Authors:  Di Shi; Gujie Mi; Mian Wang; Thomas J Webster
Journal:  Biomaterials       Date:  2018-10-24       Impact factor: 12.479

6.  Growth Media for Mixed Multispecies Oropharyngeal Biofilm Compositions on Silicone.

Authors:  Matthias Leonhard; Beata Zatorska; Doris Moser; Berit Schneider-Stickler
Journal:  Biomed Res Int       Date:  2019-07-09       Impact factor: 3.411

Review 7.  Approaches for Mitigating Microbial Biofilm-Related Drug Resistance: A Focus on Micro- and Nanotechnologies.

Authors:  Harinash Rao; Sulin Choo; Sri Raja Rajeswari Mahalingam; Diajeng Sekar Adisuri; Priya Madhavan; Abdah Md Akim; Pei Pei Chong
Journal:  Molecules       Date:  2021-03-26       Impact factor: 4.411

Review 8.  Antimicrobial photodynamic therapy (aPDT) for biofilm treatments. Possible synergy between aPDT and pulsed electric fields.

Authors:  Wanessa de Cassia Martins Antunes de Melo; Raimonda Celiešiūtė-Germanienė; Povilas Šimonis; Arūnas Stirkė
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 9.  Host Defense Peptides as Templates for Antifungal Drug Development.

Authors:  Virginia Basso; Dat Q Tran; André J Ouellette; Michael E Selsted
Journal:  J Fungi (Basel)       Date:  2020-10-23

10.  Easy Surface Functionalization and Bioconjugation of Peptides as Capture Agents of a Microfluidic Biosensing Platform for Multiplex Assay in Serum.

Authors:  Concetta Di Natale; Edmondo Battista; Vincenzo Lettera; Narayana Reddy; Gabriele Pitingolo; Raffaele Vecchione; Filippo Causa; Paolo Antonio Netti
Journal:  Bioconjug Chem       Date:  2021-06-11       Impact factor: 4.774

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.